In BRCA2, one of the splicing variants BRCA2-Δ3 (Gelli et al., 2019), has been shown to be associated with a high risk of developing breast or ovarian cancer (Muller et al., 2011; Caputo et al., 2018). Here, BRCA2 is linked to ovarian carcinoma.